ART Announces First Sale of SoftScan Optical Breast Imaging System

MONTREAL, CANADA--(Marketwire - Feb. 20, 2008) - ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce the first sale of its SoftScan® optical breast imaging system to the Sunnybrook Health Sciences Centre ('Sunnybrook") in Toronto, Canada. Sunnybrook is the first health centre to purchase a SoftScan imaging system since ART received regulatory approval from Health Canada for the commercialization of its optical breast imaging device.

Dr. Gregory Czarnota, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, and Scientist in Imaging Research at Sunnybrook Research Institute, is the principal investigator of a pilot study to determine the role for the SoftScan system in monitoring response to treatment of breast cancer, particularly neoadjuvant therapies. He works with Dr. Martin Yaffe, Senior Scientist in Imaging Research at Sunnybrook Research Institute, in advancing this programme.

source: Marketwire.com